These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 20107311

  • 1. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E.
    Gumina MR, Xu C, Chiles TC.
    Cell Cycle; 2010 Feb 15; 9(4):820-8. PubMed ID: 20107311
    [Abstract] [Full Text] [Related]

  • 2. Cyclins D3 and E go hand in hand with Cdk4/6 in diffuse large B-cell lymphoma.
    Gilmore TD, Thompson RC, Faber AC.
    Cell Cycle; 2010 Feb 01; 9(3):448-9. PubMed ID: 20130454
    [No Abstract] [Full Text] [Related]

  • 3. α-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation.
    Yang L, Wen Y, Lv G, Lin Y, Tang J, Lu J, Zhang M, Liu W, Sun X.
    Biochem Biophys Res Commun; 2017 Dec 09; 494(1-2):325-331. PubMed ID: 28993193
    [Abstract] [Full Text] [Related]

  • 4. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
    Joshi I, Minter LM, Telfer J, Demarest RM, Capobianco AJ, Aster JC, Sicinski P, Fauq A, Golde TE, Osborne BA.
    Blood; 2009 Feb 19; 113(8):1689-98. PubMed ID: 19001083
    [Abstract] [Full Text] [Related]

  • 5. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.
    Paternot S, Colleoni B, Bisteau X, Roger PP.
    Cell Cycle; 2014 Feb 19; 13(18):2879-88. PubMed ID: 25486476
    [Abstract] [Full Text] [Related]

  • 6. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.
    Bryja V, Pacherník J, Vondráček J, Souček K, Čajánek L, Horvath V, Holubcová Z, Dvořák P, Hampl A.
    Cell Prolif; 2008 Dec 19; 41(6):875-893. PubMed ID: 19040567
    [Abstract] [Full Text] [Related]

  • 7. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
    Wang GL, Shi X, Salisbury E, Sun Y, Albrecht JH, Smith RG, Timchenko NA.
    Mol Cell Biol; 2006 Apr 19; 26(7):2570-82. PubMed ID: 16537903
    [Abstract] [Full Text] [Related]

  • 8. Fangchinoline induces G1 arrest in breast cancer cells through cell-cycle regulation.
    Xing Z, Zhang Y, Zhang X, Yang Y, Ma Y, Pang D.
    Phytother Res; 2013 Dec 19; 27(12):1790-4. PubMed ID: 23401195
    [Abstract] [Full Text] [Related]

  • 9. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
    Qi Y, Tu Y, Yang D, Chen Q, Xiao J, Chen Y, Fu J, Xiao X, Zhou Z.
    J Cell Physiol; 2007 Jan 19; 210(1):63-71. PubMed ID: 17013808
    [Abstract] [Full Text] [Related]

  • 10. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
    Wang H, Nicolay BN, Chick JM, Gao X, Geng Y, Ren H, Gao H, Yang G, Williams JA, Suski JM, Keibler MA, Sicinska E, Gerdemann U, Haining WN, Roberts TM, Polyak K, Gygi SP, Dyson NJ, Sicinski P.
    Nature; 2017 Jun 15; 546(7658):426-430. PubMed ID: 28607489
    [Abstract] [Full Text] [Related]

  • 11. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
    Kang J, Sergio CM, Sutherland RL, Musgrove EA.
    BMC Cancer; 2014 Jan 20; 14():32. PubMed ID: 24444383
    [Abstract] [Full Text] [Related]

  • 12. Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest.
    Magatti M, De Munari S, Vertua E, Parolini O.
    J Cell Mol Med; 2012 Sep 20; 16(9):2208-18. PubMed ID: 22260183
    [Abstract] [Full Text] [Related]

  • 13. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
    Kaproth-Joslin KA, Li X, Reks SE, Kelley GG.
    Biochem J; 2008 Nov 01; 415(3):439-48. PubMed ID: 18588506
    [Abstract] [Full Text] [Related]

  • 14. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S, Di Liberto M, Niesvizky R, Baughn LB, Cho HJ, Hatada EN, Knowles DM, Lane J, Chen-Kiang S.
    Cancer Res; 2005 Dec 15; 65(24):11345-53. PubMed ID: 16357141
    [Abstract] [Full Text] [Related]

  • 15. cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation.
    Naderi S, Gützkow KB, Christoffersen J, Smeland EB, Blomhoff HK.
    Eur J Immunol; 2000 Jun 15; 30(6):1757-68. PubMed ID: 10898514
    [Abstract] [Full Text] [Related]

  • 16. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R.
    Oncogene; 1998 Oct 08; 17(14):1827-36. PubMed ID: 9778049
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS, Lee WJ, Lee SW, Chae HW, Kim DH, Oh Y.
    Horm Metab Res; 2010 Mar 08; 42(3):165-72. PubMed ID: 19960406
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas.
    Faber AC, Chiles TC.
    Cell Cycle; 2007 Dec 01; 6(23):2982-9. PubMed ID: 18156799
    [Abstract] [Full Text] [Related]

  • 19. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
    Scaglione-Sewell BA, Bissonnette M, Skarosi S, Abraham C, Brasitus TA.
    Endocrinology; 2000 Nov 01; 141(11):3931-9. PubMed ID: 11089522
    [Abstract] [Full Text] [Related]

  • 20. G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation.
    Juan G, Ardelt B, Li X, Mikulski SM, Shogen K, Ardelt W, Mittelman A, Darzynkiewicz Z.
    Leukemia; 1998 Aug 01; 12(8):1241-8. PubMed ID: 9697879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.